The EBMT/EHA CAR-T cell handbook / Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele, editors.
2022
RM276 .E26 2022
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
The EBMT/EHA CAR-T cell handbook / Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele, editors.
Variant Title
European Society for Blood and Marrow Transplantation/European Hematology Association chimeric antigen receptor therapy cell handbook
ISBN
9783030943530 electronic book
3030943534 electronic book
9783030943523
3030943534 electronic book
9783030943523
Published
Cham : Springer, [2022]
Language
English
Description
1 online resource : illustrations (some color)
Item Number
10.1007/978-3-030-94353-0 doi
Call Number
RM276 .E26 2022
Dewey Decimal Classification
616.0798
610.73
610.73
Summary
This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers' knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers' knowledge and practice skills.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Description based on online resource; title from HTML title page (viewed on October 24, 2022).
Added Author
Added Corporate Author
Available in Other Form
Print version: 9783030943523
Print version: 9783030943547
Print version: 9783030943547
Linked Resources
Record Appears in
Table of Contents
1. Introduction
2. The science behind CAR-T Cells
3. Manufacturing CAR-T Cells: the supply chain
4. Clinical indications for CAR-T Cells
5. Clinical management of patients treated with CAR-T Cells
6. Access to CAR-T cells. .
2. The science behind CAR-T Cells
3. Manufacturing CAR-T Cells: the supply chain
4. Clinical indications for CAR-T Cells
5. Clinical management of patients treated with CAR-T Cells
6. Access to CAR-T cells. .